Prevention and Control

癌症预防和控制项目旨在通过确定可控的危险因素、特殊的高危目标人群以及危险和肿瘤侵袭性的分子标记来降低癌症的发病率、发病率和死亡率。利用这些知识，项目成员寻求开发和测试干预策略，并通过将这些知识转化为实践，建立新的护理标准。目前的资助周期是该项目巨大增长和发展的时期，其成员帮助在项目1（癌症生物学）和项目3（实体肿瘤）中建立了癌症预防和控制的新优势。一个强有力的每月癌症预防和控制系列研讨会加强了内部和项目间的合作，特别强调帮助初级研究人员和受训人员。我们的领导团队在三个重点领域(1)幸存者和症状管理、（2)监测和流行病学以及(3)服务不足人群）的招聘和发展方面的投资取得了进展。现在有27个成员国，14个

The Cancer Prevention and Control Program aims to reduce cancer incidence, morbidity, and mortality by identifying controllable risk factors, special high-risk target groups, and molecular markers of risk and tumor aggressiveness. Using such knowledge, the program members seek to develop and test interventional strategies, and, by the translation of such knowledge into practice, to establish new standards of care. The current grant cycle has been a time of tremendous growth and development in this program, and its members have helped create new strengths in cancer prevention and control in Programs 1 (Cancer Biology) and 3 (Solid Tumors). A robust monthly Cancer Prevention and Control Seminar Series has enhanced collaborations internally and interprogrammatically, with a particular emphasis on aiding junior investigators and trainees. Progress has evolved from the investment of our leadership team in recruitment and development of faculty in our three focus areas: (1) survivorship and symptom management, (2) surveillance and epidemiology, and (3) underserved populations. There are now 27 members, 14 full and 13 associate, in this program from 14 different departments and institutes of the University. During the past grant cycle, the cancer focus of program investigators has been enhanced by the recruitment of highly-focused investigators and by terminating memberships of members whose cancer focus was deemed insufficient. The members of this group have $10.2 million in grant funding within 49 projects including $3.2 million in NCI funding (16 projects). This productive group has published 123 manuscripts in scientific literature in the past five years. Investigators are increasingly conducting intervention studies, and program investigators are helping establish the standard of care in a number of high priority areas.